313 related articles for article (PubMed ID: 9435230)
1. Modulation of cell death by Bcl-XL through caspase interaction.
Clem RJ; Cheng EH; Karp CL; Kirsch DG; Ueno K; Takahashi A; Kastan MB; Griffin DE; Earnshaw WC; Veliuona MA; Hardwick JM
Proc Natl Acad Sci U S A; 1998 Jan; 95(2):554-9. PubMed ID: 9435230
[TBL] [Abstract][Full Text] [Related]
2. Acceleration of apoptotic cell death after the cleavage of Bcl-XL protein by caspase-3-like proteases.
Fujita N; Nagahashi A; Nagashima K; Rokudai S; Tsuruo T
Oncogene; 1998 Sep; 17(10):1295-304. PubMed ID: 9771973
[TBL] [Abstract][Full Text] [Related]
3. Conversion of Bcl-2 to a Bax-like death effector by caspases.
Cheng EH; Kirsch DG; Clem RJ; Ravi R; Kastan MB; Bedi A; Ueno K; Hardwick JM
Science; 1997 Dec; 278(5345):1966-8. PubMed ID: 9395403
[TBL] [Abstract][Full Text] [Related]
4. Cell-specific induction of apoptosis by microinjection of cytochrome c. Bcl-xL has activity independent of cytochrome c release.
Li F; Srinivasan A; Wang Y; Armstrong RC; Tomaselli KJ; Fritz LC
J Biol Chem; 1997 Nov; 272(48):30299-305. PubMed ID: 9374516
[TBL] [Abstract][Full Text] [Related]
5. Bcl-XL interacts with Apaf-1 and inhibits Apaf-1-dependent caspase-9 activation.
Hu Y; Benedict MA; Wu D; Inohara N; Núñez G
Proc Natl Acad Sci U S A; 1998 Apr; 95(8):4386-91. PubMed ID: 9539746
[TBL] [Abstract][Full Text] [Related]
6. The Bcl-xL and Bax-alpha control points: modulation of apoptosis induced by cancer chemotherapy and relation to TPCK-sensitive protease and caspase activation.
Schmitt E; Sané AT; Steyaert A; Cimoli G; Bertrand R
Biochem Cell Biol; 1997; 75(4):301-14. PubMed ID: 9493953
[TBL] [Abstract][Full Text] [Related]
7. Bcl-xL acts downstream of caspase-8 activation by the CD95 death-inducing signaling complex.
Medema JP; Scaffidi C; Krammer PH; Peter ME
J Biol Chem; 1998 Feb; 273(6):3388-93. PubMed ID: 9452459
[TBL] [Abstract][Full Text] [Related]
8. 'Loop' domain deletional mutant of Bcl-xL is as effective as p29Bcl-xL in inhibiting radiation-induced cytosolic accumulation of cytochrome c (cyt c), caspase-3 activity, and apoptosis.
Burri SH; Kim CN; Fang G; Chang BS; Perkins C; Harris W; Davis LW; Thompson CB; Bhalla KN
Int J Radiat Oncol Biol Phys; 1999 Jan; 43(2):423-30. PubMed ID: 10030271
[TBL] [Abstract][Full Text] [Related]
9. Curcumin (diferuloylmethane) induces apoptosis through activation of caspase-8, BID cleavage and cytochrome c release: its suppression by ectopic expression of Bcl-2 and Bcl-xl.
Anto RJ; Mukhopadhyay A; Denning K; Aggarwal BB
Carcinogenesis; 2002 Jan; 23(1):143-50. PubMed ID: 11756235
[TBL] [Abstract][Full Text] [Related]
10. Bcl-2 expression prevents activation of the ICE protease cascade.
Shimizu S; Eguchi Y; Kamiike W; Matsuda H; Tsujimoto Y
Oncogene; 1996 Jun; 12(11):2251-7. PubMed ID: 8649764
[TBL] [Abstract][Full Text] [Related]
11. Two CD95 (APO-1/Fas) signaling pathways.
Scaffidi C; Fulda S; Srinivasan A; Friesen C; Li F; Tomaselli KJ; Debatin KM; Krammer PH; Peter ME
EMBO J; 1998 Mar; 17(6):1675-87. PubMed ID: 9501089
[TBL] [Abstract][Full Text] [Related]
12. Bcl-2 and Bcl-xL block apoptosis as well as necrosis: possible involvement of common mediators in apoptotic and necrotic signal transduction pathways.
Tsujimoto Y; Shimizu S; Eguchi Y; Kamiike W; Matsuda H
Leukemia; 1997 Apr; 11 Suppl 3():380-2. PubMed ID: 9209397
[TBL] [Abstract][Full Text] [Related]
13. Bcl-xL blocks transforming growth factor-beta 1-induced apoptosis by inhibiting cytochrome c release and not by directly antagonizing Apaf-1-dependent caspase activation in prostate epithelial cells.
Chipuk JE; Bhat M; Hsing AY; Ma J; Danielpour D
J Biol Chem; 2001 Jul; 276(28):26614-21. PubMed ID: 11320089
[TBL] [Abstract][Full Text] [Related]
14. The C. elegans orthologue ceBNIP3 interacts with CED-9 and CED-3 but kills through a BH3- and caspase-independent mechanism.
Cizeau J; Ray R; Chen G; Gietz RD; Greenberg AH
Oncogene; 2000 Nov; 19(48):5453-63. PubMed ID: 11114722
[TBL] [Abstract][Full Text] [Related]
15. Bcl-xL functions downstream of caspase-8 to inhibit Fas- and tumor necrosis factor receptor 1-induced apoptosis of MCF7 breast carcinoma cells.
Srinivasan A; Li F; Wong A; Kodandapani L; Smidt R; Krebs JF; Fritz LC; Wu JC; Tomaselli KJ
J Biol Chem; 1998 Feb; 273(8):4523-9. PubMed ID: 9468507
[TBL] [Abstract][Full Text] [Related]
16. Overexpression of Bcl-2 or Bcl-xL inhibits Ara-C-induced CPP32/Yama protease activity and apoptosis of human acute myelogenous leukemia HL-60 cells.
Ibrado AM; Huang Y; Fang G; Liu L; Bhalla K
Cancer Res; 1996 Oct; 56(20):4743-8. PubMed ID: 8840993
[TBL] [Abstract][Full Text] [Related]
17. Alphaviruses induce apoptosis in Bcl-2-overexpressing cells: evidence for a caspase-mediated, proteolytic inactivation of Bcl-2.
Grandgirard D; Studer E; Monney L; Belser T; Fellay I; Borner C; Michel MR
EMBO J; 1998 Aug; 17(5):1268-78. PubMed ID: 9482724
[TBL] [Abstract][Full Text] [Related]
18. Bak BH3 peptides antagonize Bcl-xL function and induce apoptosis through cytochrome c-independent activation of caspases.
Holinger EP; Chittenden T; Lutz RJ
J Biol Chem; 1999 May; 274(19):13298-304. PubMed ID: 10224090
[TBL] [Abstract][Full Text] [Related]
19. Involvement of CPP32/Caspase-3 in c-Myc-induced apoptosis.
Kangas A; Nicholson DW; Hölttä E
Oncogene; 1998 Jan; 16(3):387-98. PubMed ID: 9467964
[TBL] [Abstract][Full Text] [Related]
20. Ligation of CD40 potentiates Fas-mediated activation of the cysteine protease CPP32, cleavage of its death substrate PARP, and apoptosis in Ramos-Burkitt lymphoma B cells.
An S; Yap D; Knox KA
Cell Immunol; 1997 Nov; 181(2):139-52. PubMed ID: 9398401
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
